Allozymes Welcomes Dr. Andreas Reindl as Chief Operating Officer to Accelerate Strategic Growth

Allozymes is excited to welcome Dr. Andreas Reindl as our Chief Operating Officer, supporting our transition from service-focused innovation to scalable, platform-driven growth.

With the growing demand for faster, more effective enzyme discovery, Andreas joins us at a pivotal moment in our trajectory. His arrival signals Allozymes’ sharpened focus on execution — aligning scientific leadership with operational excellence to meet growing partner needs.

Andreas brings more than 20 years of experience across industrial biotech, and strategic operations. He has held senior roles at BASF and Clariant, and advised early-stage startups across Europe and Asia on commercial scale-up, business modeling, and investor readiness. His background spans enzyme engineering, molecular genetics, and biotechnologies for renewables — all central to Allozymes’ mission to industrialize biology.

“Allozymes has built a powerful discovery engine with commercial success. Now it’s time to further expand our footprint globally. My role is to design a strategy, align operations across teams, and accelerate delivery to market — reliably, and at scale.”
— Dr. Andreas Reindl, COO, Allozymes

As COO, Andreas will oversee strategic operations, commercial enablement, and cross-functional execution — ensuring that Allozymes’ platform advances from technical proof to scalable impact. His responsibilities include:

• Leading internal alignment between R&D, operations, and commercial teams
  
  
• Strengthening delivery pipelines to meet customer and partner milestones
  
  
• Driving strategic planning and operational KPIs for sustainable growth
  
  
• Supporting business development with industry insight and executional rigor
  

His leadership approach combines empathy with accountability — bringing clarity to complex environments while fostering a culture of ownership.

Andreas’ leadership marks a key step in Allozymes’ broader growth strategy: not only to push the frontiers of enzyme engineering, but to deliver solutions that perform in real-world markets. His experience across the chemical and biotech industries supports customers who are ready to move to a new level of innovation.

“For our customers, it's not just about innovation. It's about getting results faster, with confidence. My goal is to make Allozymes a partner they can count on, from first engagement to commercial success.”
— Dr. Andreas Reindl

We’re excited to have him onboard — and even more excited about what we’ll build next.

Andreas’ Opening Message

I am highly energized to leverage my expertise and enthusiasm to bring Allozymes to the next level. By aligning our enzyme technology with a dynamic go-to-market strategy and fostering a culture of collaboration and innovation, I will help the company realize its full potential and deliver exceptional value to global customers. This role is not just a position for me, it is a mission I will be deeply committed to.